ClinicalTrials.Veeva

Menu

Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis

T

Taipei Veterans General Hospital

Status

Enrolling

Conditions

Idiopathic Pulmonary Fibrosis

Treatments

Device: "LARGAN" ECG Holter

Study type

Observational

Funder types

Other

Identifiers

NCT06027372
2020-04-016BC

Details and patient eligibility

About

The goal of this observational study is to compare the overnight heart rate variability (HRV) and nocturnal oxygen saturation (SpO2) in patients with idiopathic pulmonary fibrosis (IPF). The main questions it aims to answer are: (1). if there are correlations between pulmonary function test and HRV and overnight SpO2; (2). if HRV and SpO2 can predict the occurrence of acute exacerbation in patients with IPF. Participants will be asked to examine pulmonary function test (including lung volumes and six-minute walk test) and wear pulse oxygenation recorder and "LARGAN" ECG Holter" ("LARGAN HEALTH TECHNOLOGY" Sleep Apnea And Sleep Quality Examination System) during sleep.

Enrollment

70 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • individuals meet the diagnosis of idiopathic pulmonary fibrosis
  • individuals agree to participate this study and sign the informed consent
  • individuals have cognitive and behavioral abilities

Exclusion criteria

  • age less than 50 years old
  • individuals refuse to participate this study and sign the informed consent
  • individuals of unclear consciousness

Trial design

70 participants in 2 patient groups

IPF patients with acute exacerbation during test period
Description:
IPF patients completing pulmonary function, overnight SpO2 monitor and "LARGAN" ECG Holter reqire hospitalization during test period.
Treatment:
Device: "LARGAN" ECG Holter
IPF patients without acute exacerbation during test period
Description:
IPF patients completing pulmonary function, overnight SpO2 monitor and "LARGAN" ECG Holter remain stable during test period.
Treatment:
Device: "LARGAN" ECG Holter

Trial contacts and locations

1

Loading...

Central trial contact

Fang-Chi Lin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems